feed,title,long_url,short_url
Benzinga,"China Pembrolizumab Market Report 2021: Revenue in 2020 Reached CNY 294.75 Million, a CAGR of 284.67% for 2018-2020 - Forecast to 2025",https://benzinga.com/pressreleases/21/04/n20730981/china-pembrolizumab-market-report-2021-revenue-in-2020-reached-cny-294-75-million-a-cagr-of-284-67,
